These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36436996)

  • 21. Pyruvamide-promoted deamination and decarboxylation of amines and amino acids: a system modelling histidine decarboxylase.
    Owen TC; Young PR
    FEBS Lett; 1974 Aug; 43(3):308-12. PubMed ID: 4415413
    [No Abstract]   [Full Text] [Related]  

  • 22. A Review of Recent Developments and Progress in Computational Drug Repositioning.
    Shi W; Chen X; Deng L
    Curr Pharm Des; 2020; 26(26):3059-3068. PubMed ID: 31951162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico repositioning of approved drugs for rare and neglected diseases.
    Ekins S; Williams AJ; Krasowski MD; Freundlich JS
    Drug Discov Today; 2011 Apr; 16(7-8):298-310. PubMed ID: 21376136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro screening for drug repositioning.
    Wilkinson GF; Pritchard K
    J Biomol Screen; 2015 Feb; 20(2):167-79. PubMed ID: 25527136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug repositioning for orphan diseases.
    Sardana D; Zhu C; Zhang M; Gudivada RC; Yang L; Jegga AG
    Brief Bioinform; 2011 Jul; 12(4):346-56. PubMed ID: 21504985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trypanocidal Effect of Isotretinoin through the Inhibition of Polyamine and Amino Acid Transporters in Trypanosoma cruzi.
    Reigada C; Valera-Vera EA; Sayé M; Errasti AE; Avila CC; Miranda MR; Pereira CA
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005472. PubMed ID: 28306713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug repositioning for enzyme modulator based on human metabolite-likeness.
    Lee YH; Choi H; Park S; Lee B; Yi GS
    BMC Bioinformatics; 2017 May; 18(Suppl 7):226. PubMed ID: 28617219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug Discovery Targeting an Amino Acid Transporter for Diagnosis and Therapy].
    Wiriyasermkul P; Moriyama S; Kongpracha P; Nagamori S
    Yakugaku Zasshi; 2021; 141(4):501-510. PubMed ID: 33790117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico drug repositioning: what we need to know.
    Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
    Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug combination therapy increases successful drug repositioning.
    Sun W; Sanderson PE; Zheng W
    Drug Discov Today; 2016 Jul; 21(7):1189-95. PubMed ID: 27240777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of intestinal health by branched-chain amino acids.
    Zhou H; Yu B; Gao J; Htoo JK; Chen D
    Anim Sci J; 2018 Jan; 89(1):3-11. PubMed ID: 29164733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning.
    Wang R; Li S; Cheng L; Wong MH; Leung KS
    BMC Bioinformatics; 2019 Dec; 20(Suppl 26):628. PubMed ID: 31839008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiological and pathological roles of branched-chain amino acids in the regulation of protein and energy metabolism and neurological functions.
    Shimomura Y; Kitaura Y
    Pharmacol Res; 2018 Jul; 133():215-217. PubMed ID: 29803540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
    Kawaguchi T; Izumi N; Charlton MR; Sata M
    Hepatology; 2011 Sep; 54(3):1063-70. PubMed ID: 21563202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug repositioning: re-investigating existing drugs for new therapeutic indications.
    Padhy BM; Gupta YK
    J Postgrad Med; 2011; 57(2):153-60. PubMed ID: 21654146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
    Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
    BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-based drug repositioning: Potential and limits.
    Adasme MF; Parisi D; Sveshnikova A; Schroeder M
    Semin Cancer Biol; 2021 Jan; 68():192-198. PubMed ID: 32032699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CHROMATOGRAPHIC SEPARATION OF PYRIDOXYL DERIVATIVES OF AMINO ACIDS.
    TURANO C; FASELLA P; VECCHINI P; GIARTOSIO A
    J Chromatogr; 1964 Apr; 14():201-4. PubMed ID: 14165955
    [No Abstract]   [Full Text] [Related]  

  • 39. PIMD: An Integrative Approach for Drug Repositioning Using Multiple Characterization Fusion.
    He S; Wen Y; Yang X; Liu Z; Song X; Huang X; Bo X
    Genomics Proteomics Bioinformatics; 2020 Oct; 18(5):565-581. PubMed ID: 33075523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards drug repositioning: a unified computational framework for integrating multiple aspects of drug similarity and disease similarity.
    Zhang P; Wang F; Hu J
    AMIA Annu Symp Proc; 2014; 2014():1258-67. PubMed ID: 25954437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.